Tulasigeri M Totiger
Overview
Explore the profile of Tulasigeri M Totiger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mehra S, Srinivasan S, Singh S, Zhou Z, Garrido V, De Castro Silva I, et al.
Am J Physiol Gastrointest Liver Physiol
. 2022 Sep;
323(4):G375-G386.
PMID: 36098401
Heavy alcohol consumption is the dominant risk factor for chronic pancreatitis (CP); however, treatment and prevention strategies for alcoholic chronic pancreatitis (ACP) remains limited. The present study demonstrates that ACP...
12.
Spieler B, Giret T, Welford S, Totiger T, Mihaylov I
Biomedicines
. 2022 May;
10(5).
PMID: 35625911
Purpose: Combined radiotherapy (RT) and immune checkpoint-inhibitor (ICI) therapy can act synergistically to enhance tumor response beyond what either treatment can achieve alone. Alongside the revolutionary impact of ICIs on...
13.
Wang E, Mi X, Thompson M, Montoya S, Notti R, Afaghani J, et al.
N Engl J Med
. 2022 Feb;
386(8):735-743.
PMID: 35196427
Background: Covalent (irreversible) Bruton's tyrosine kinase (BTK) inhibitors have transformed the treatment of multiple B-cell cancers, especially chronic lymphocytic leukemia (CLL). However, resistance can arise through multiple mechanisms, including acquired...
14.
Mihaylov I, Totiger T, Giret T, Wang D, Spieler B, Welford S
PLoS One
. 2021 Aug;
16(8):e0255923.
PMID: 34428218
Purpose: Immunotherapy (IT) and radiotherapy (RT) can act synergistically, enhancing antitumor response beyond what either treatment can achieve separately. Anecdotal reports suggest that these results are in part due to...
15.
Hara D, Tao W, Totiger T, Pourmand A, Dogan N, Ford J, et al.
Int J Radiat Oncol Biol Phys
. 2021 May;
111(1):220-232.
PMID: 33964351
Purpose: The gold nanoparticle (GNP) as a promising theranostic probe has been increasingly studied. The tumor-targeting efficiency of GNPs is crucial to increase the therapeutic ratio. In this study, we...
16.
Udayakumar T, Betancourt D, Ahmad A, Tao W, Totiger T, Patel M, et al.
Mol Cancer Res
. 2020 May;
18(8):1232-1243.
PMID: 32366674
Vesicular stomatitis virus (VSV) expressing IFNβ induces apoptosis in multiple tumor models while maintaining an excellent safety profile. VSV-IFNβ is oncoselective due to permissive replication in cells with an altered...
17.
Totiger T, Srinivasan S, Jala V, Lamichhane P, Dosch A, Gaidarski 3rd A, et al.
Mol Cancer Ther
. 2018 Nov;
18(2):301-311.
PMID: 30404927
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy and is highly resistant to standard treatment regimens. Targeted therapies against , a mutation present in an overwhelming majority of PDAC cases,...
18.
Singh G, Totiger T, Seshagiri P
Am J Stem Cells
. 2013 May;
1(2):163-73.
PMID: 23671805
Derivation of embryonic stem (ES)-cell lines from genetically non-permissive mouse strains, such as FVB/N, has been difficult, despite this strain offering advantages for mouse transgenesis for developmental studies. We earlier...